Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
SK Bioscience
Pharma
Astellas, Takeda, Chugai and more—Fierce Pharma Asia
Astellas CEO lays out the company's dealmaking plans. Takeda cuts jobs ahead of Trintellix patent expiry. Chugai seeks name recognition. And more.
Angus Liu
Jan 23, 2026 9:05am
CEPI funds $30M Ebola vaccine collab with Merck, SK and others
Jan 22, 2026 11:16am
SK defeats Pfizer in Korean patent feud
May 21, 2025 9:39am
SK pharmteco to build $260M peptide production plant in Korea
Sep 30, 2024 3:46pm
Daiichi-Merck, Wegovy, Takeda CEO—Fierce Pharma Asia
Jun 28, 2024 8:40am
SK Bioscience ponies up $244M for 60% stake in IDT Biologika
Jun 27, 2024 11:50am
